DEXCOM INC — Director's Dealing 2022

Nov 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2022-11-08

Reporting Person: Naganathan Girish (EVP Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-08	Common Stock	A	31449	$0.001	Acquired	31449	Direct

Footnotes

F1: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in four equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2: Included in this number are 31,449 unvested restricted stock units, 31,449 of which were granted on November 8, 2022 and shall vest through November 8, 2026.